1 completed, 1 recruiting, 1 terminated, 1 unknown. 3 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Daniel Moore: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Animal and Microbial-based Dietary Protein Efficiency in Adults Yeast Protein Supplement, Whey Protein Isolate Supplement, Collagen Hydrolysate Supplement - Protein Metabolism | Not applicable | Recruiting | Daniel Moore | 13 | 2025-07-01 | 2025-08-29 |
| Influence of Leucine Enriched Amino Acids on Myofibrillar and Collagen Protein Synthesis Leucine enriched amino acids, Carbohydrate Placebo - Interventional | Not applicable | Unknown | Daniel Moore | 8 | 2022-10-01 | 2023-11-13 |
| Protein Requirements for Active Children Amino Acid Intake - Increased Metabolic Requirement, Healthy | Not applicable | Completed | Daniel Moore | 8 | 2016-10-22 | 2019-03-29 |
| Safety Study of Latanoprost Slow Release Insert Latanoprost, Arm 2, Latanoprost SR insert - Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT) | Phase 1 | Terminated | Daniel Moore | 12 | 2011-01-01 | 2014-12-08 |
Glaucoma, Open-Angle (1) · Ocular Hypertension (1)
DMAC2L protein, human (1) · Latanoprost (1)
Canada (3) · United States (1)